News
Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of ...
Edema is a medical condition characterized by the accumulation of excess fluid in the body’s tissues, leading to swelling and ...
The Interventional Oncology Market is poised for significant growth, projected to reach USD 3.9 billion by 2025, expanding at ...
Hiring the right Laravel development company is not just about technical skills. It's about finding a team that understands ...
Introduction: The Convergence of AI and Life SciencesTraditionally, drug discovery is a time-consuming and costly process, ...
Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...
Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, is proud to announce the ...
A recent video produced by Vapourtec highlights the patented automatic Variable Bed Flow Reactor (VBFR) demonstrating fully automated solid phase peptide synthesis (SPPS).The process begins with ...
RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis with a level ...
Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and safety of Phesgo’s administration outside of clinical settings, for example at home1-4Phesgo ...
Update on CAPItello-280 Phase III trial of Truqap in metastatic castration-resistant prostate cancer
AstraZeneca is discontinuing the CAPItello-280 Phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared ...
Online Sampling at TrySalonpas.com & PruebaSalonpas.com in the Month of May FLORHAM PARK, NJ / ACCESS Newswire / April 30, 2025 / Hisamitsu America, the marketers of Salonpas®, the world's No.1 Brand ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results